Will Guidant Return To Pharma Roots After 10 Years As Stand-Alone Entity?

Guidant's cardiac surgery device and guiding catheter segments offer an attractive fit with Johnson & Johnson, though ICD market access and drug-eluting stent synergies would be the true drivers of any merger